difference between semaglutide and retatrutide vs Tirzepatide: GLP-3 Facts explained Retatrutide for weight loss: Study

Discuss these risks with your provider

Subphenotype-dependent benefits of bariatric surgery for individuals at risk for type 2 diabetes

Tao X, Zhang X, Ge SQ, Zhang EH, Zhang B

A taper reverses this ladder over a similar 20-to-24-week window: Weeks 1 to 4: reduce to 12.5 mg weekly Weeks 5 to 8: reduce to 10 mg weekly Weeks 9 to 12: reduce to 7.5 mg weekly Weeks 13 to 16: reduce to 5 mg weekly Weeks 17 to 20: reduce to 2.5 mg weekly Week 21: discontinue, or evaluate ongoing need at 2.5 mg The SURMOUNT-3 trial (N=579) showed that patients who completed an intensive lifestyle intervention before starting tirzepatide lost an additional 18.4% on-drug [9]